Heron Therapeuti
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | -288.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -14.3% | +16.7% | -64.3% | -123.4% | – | +18.7% | -4.6% | -31.7% | +42.0% | -154.7% | – | +42.6% | -13.6% | -36.2% | -21.1% | +10.1% | +69.0% | +73.6% | +27.0% | +49.7% | +39.3% | -1.2% | +35.1% | +39.3% | +6.1% | -4.4% | +0.3% | -14.0% | -7.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +2.2% | +53.8% | +8.1% | +203.3% | +90.0% | -25.9% | +78.0% | +80.8% | +17.7% | +9.3% | +54.1% | -2.3% | -6.7% | -8.3% | -23.6% | -60.5% | -20.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +906.5% | -17.5% | +58.4% | +82.3% | +17.8% | +9.5% | +54.1% | -1.0% | -5.1% | -12.3% | – | – | – | |
| – | -400.0% | – | – | – | – | – | – | – | -107.2% | – | -40.1% | -242.4% | – | – | – | -28.5% | +150.6% | +115.1% | -43.2% | +226.4% | -149.2% | – | – | -144.5% | – | – | – | -264.4% | – | |
| – | +300.0% | -3.6% | -88.9% | -40.3% | +54.6% | +55.4% | -41.6% | -23.1% | +63.7% | -40.8% | +157.2% | -38.0% | -99.3% | +3,800.0% | +557.7% | +89.5% | +73.4% | -14.7% | -24.5% | +188.7% | -18.6% | +259.2% | -22.0% | -4.8% | -55.6% | -39.6% | -15.3% | +10.4% | -81.4% | |
| – | +42.9% | +180.0% | -85.7% | – | -60.4% | +33.0% | -31.0% | -138.6% | – | -251.7% | – | -93.9% | -9.7% | -112.7% | +557.7% | +89.5% | +73.4% | -14.7% | +3,861.1% | – | -48.0% | -3,699.8% | -92.2% | – | -84.3% | -110.2% | – | +4.0% | -14.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +46.7% | +278,213.6% | +1.4% | +122.2% | -94.6% | +4,175.4% | +20.0% | -51.3% | -95.1% | -22.2% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | -150.0% | +0.0% | – | +0.0% | +572,834.6% | -100.0% | – | -100.0% | – | |
| – | -39.4% | -107.0% | – | -611.3% | – | +14.0% | +10.7% | +14,372.3% | -99.0% | -33.6% | +47,059.5% | -99.9% | +14,738.9% | -99.0% | +31,197.4% | +122.1% | +14.4% | +1.4% | +122.2% | -58.4% | +411.2% | +21.7% | -47.9% | -95.1% | +1,613.7% | -51.9% | -27.9% | -98.3% | +1,434.8% | |
| – | +933.3% | -248.4% | – | – | -203.1% | – | – | – | -73.8% | +95.3% | +1,920.5% | -175.5% | – | – | – | +124.0% | -47.1% | -97.9% | +545.6% | -2,565.7% | – | -186.0% | – | -17.0% | -143.9% | – | – | -121.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -297.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.